xanderla implantaat süstlis
teva b.v. - gosereliin - implantaat süstlis - 3,6mg 2tk; 3,6mg 3tk
reseligo implantaat süstlis
zentiva k.s. - gosereliin - implantaat süstlis - 3,6mg 3tk
xanderla implantaat süstlis
teva b.v. - gosereliin - implantaat süstlis - 10,8mg 3tk; 10,8mg 2tk
reseligo implantaat süstlis
zentiva k.s. - gosereliin - implantaat süstlis - 10,8mg 1tk; 10,8mg 3tk
firmagon
ferring pharmaceuticals a/s - degareliks - eesnäärmevähk - endokriinset ravi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
bicalutamide - teva õhukese polümeerikattega tablett
teva pharma b.v. - bikalutamiid - õhukese polümeerikattega tablett - 50mg 30tk; 50mg 60tk; 50mg 100tk; 50mg 40tk; 50mg 50tk; 50mg 28tk; 50mg 84tk; 50mg 90tk; 50mg 56tk
anastrozole accord 1mg õhukese polümeerikattega tablett
accord healthcare b.v. - anastrosool - õhukese polümeerikattega tablett - 1mg 14tk; 1mg 20tk; 1mg 30tk; 1mg 50tk; 1mg 98tk; 1mg 300tk; 1mg 100tk; 1mg 60tk
bicalutamide grindeks 50mg õhukese polümeerikattega tablett
grindeks as - bikalutamiid - õhukese polümeerikattega tablett - 50mg 14tk; 50mg 60tk; 50mg 28tk; 50mg 30tk; 50mg 10tk; 50mg 50tk
arimidex õhukese polümeerikattega tablett
laboratoires juvise pharmaceuticals - anastrosool - õhukese polümeerikattega tablett - 1mg 84tk; 1mg 28tk; 1mg 98tk; 1mg 300tk; 1mg 20tk; 1mg 30tk; 1mg 100tk